Our scientists from the University of Glasgow have had a huge breakthrough in pancreatic cancer treatment. They’ve developed a new way to predict who will respond to drugs targeting damaged DNA in pancreatic cancer; big progress for this notoriously hard to treat cancer with a stubbornly low survival rate. The team used cells grown in the lab and mini replicas of patients’ tumours (organoids) to identify markers that can predict which tumours will respond to drugs that target damaged DNA. They’r